TRAFERMIN Drug Record

  • TRAFERMIN chembl:CHEMBL2108081

    Alternate Names:

    TRAFERMIN
    CAB-2001
    FIBLAST

    Drug Info:

    FDA Approval not approved
    Drug Class protein
    Drug Indications for treatment of periodontitis,for treatment of diabetic foot ulcers
    (0 More Sources)

    Publications:

  • TRAFERMIN   FGFR2

    Interaction Score: 0.61

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name trafermin, fibro/
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TTD

  • TRAFERMIN   FGFR4

    Interaction Score: 0.59

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name trafermin, fibro/
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TRAFERMIN   FGFR3

    Interaction Score: 0.25

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name trafermin, fibro/
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TRAFERMIN   FGFR1

    Interaction Score: 0.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name trafermin, fibro/

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TdgClinicalTrial: TRAFERMIN

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of periodontitis,for treatment of diabetic foot ulcers
    Drug Class protein
    FDA Approval not approved

    Publications:

  • TTD: Trafermin

    • Version: 2020.06.01

    Alternate Names:
    D0KV1Q TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL2108081

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: